{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:23:22Z","timestamp":1791912202573,"version":"4.3.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-69054-7","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T12:45:34Z","timestamp":1731933934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Viral reactivation and clinical outcomes in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)"],"prefix":"10.1038","volume":"14","author":[{"given":"Linus C. E.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehena","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen J. L.","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Wei","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiu Ming","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haur Yueh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"69054_CR1","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1001\/archdermatol.2012.1079","volume":"148","author":"HY Lee","year":"2012","unstructured":"Lee, H. Y., Walsh, S. & Creamer, D. Initial presentation of DRESS: Often misdiagnosed as infections. Arch. Dermatol. 148, 1085\u20131087 (2012).","journal-title":"Arch. Dermatol."},{"key":"69054_CR2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","volume":"124","author":"P Cacoub","year":"2011","unstructured":"Cacoub, P. et al. The DRESS syndrome: A literature review. Am. J. Med. 124, 588\u2013597 (2011).","journal-title":"Am. J. Med."},{"key":"69054_CR3","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/bjd.12501","volume":"169","author":"S Kardaun","year":"2013","unstructured":"Kardaun, S. et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): An original multisystem adverse drug reaction Results from the prospective RegiSCAR study. Br. J. Dermatol. 169, 1071\u201380 (2013).","journal-title":"Br. J. Dermatol."},{"key":"69054_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/bjd.12081","volume":"168","author":"S Walsh","year":"2013","unstructured":"Walsh, S. et al. Drug reaction with eosinophilia and systemic symptoms: Is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases. Br. J. Dermatol. 168, 391\u2013401 (2013).","journal-title":"Br. J. Dermatol."},{"key":"69054_CR5","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1001\/archdermatol.2010.198","volume":"146","author":"Y-C Chen","year":"2010","unstructured":"Chen, Y.-C., Chiu, H.-C. & Chu, C.-Y. Drug reaction with eosinophilia and systemic symptoms: A retrospective study of 60 cases. Arch. Dermatol. 146, 1373\u20131379 (2010).","journal-title":"Arch. Dermatol."},{"key":"69054_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jaad.2012.08.009","volume":"68","author":"Y-C Chen","year":"2013","unstructured":"Chen, Y.-C., Chang, C.-Y., Cho, Y.-T., Chiu, H.-C. & Chu, C.-Y. Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: A retrospective cohort study from Taiwan. J. Am. Acad. Dermatol. 68, 459\u2013465 (2013).","journal-title":"J. Am. Acad. Dermatol."},{"key":"69054_CR7","first-page":"542","volume":"49","author":"P Tennis","year":"1997","unstructured":"Tennis, P. & Stern, R. S. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study. J. Neurol. 49, 542\u2013546 (1997).","journal-title":"J. Neurol."},{"key":"69054_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/tpj.2013.40","volume":"14","author":"E Genin","year":"2014","unstructured":"Genin, E. et al. HLA-A* 31: 01 and different types of carbamazepine-induced severe cutaneous adverse reactions: An international study and meta-analysis. Pharmacogenomics J. 14, 281 (2014).","journal-title":"Pharmacogenomics J."},{"key":"69054_CR9","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"S-I Hung","year":"2005","unstructured":"Hung, S.-I. et al. HLA-B* 5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc. Natl. Acad. Sci. USA 102, 4134\u20134139 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69054_CR10","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.jid.2018.02.004","volume":"138","author":"W-T Chen","year":"2018","unstructured":"Chen, W.-T. et al. The function of HLA-B* 13: 01 involved in the pathomechanism of dapsone-induced severe cutaneous adverse reactions. J. Investig. Dermatol. 138, 1546\u20131554 (2018).","journal-title":"J. Investig. Dermatol."},{"key":"69054_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.09.041","volume":"135","author":"C-H Lin","year":"2015","unstructured":"Lin, C.-H. et al. Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B* 58: 01-restricted activation of drug-specific T cells and molecular interaction. J. Allergy Clin. Immunol. 135, 1063-5 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"69054_CR12","doi-asserted-by":"publisher","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","volume":"182","author":"R Takahashi","year":"2009","unstructured":"Takahashi, R. et al. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J. Immunol. 182, 8071\u20138079 (2009).","journal-title":"J. Immunol."},{"key":"69054_CR13","doi-asserted-by":"publisher","first-page":"46ra62","DOI":"10.1126\/scitranslmed.3001116","volume":"2","author":"D Picard","year":"2010","unstructured":"Picard, D. et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): A multiorgan antiviral T cell response. Sci. Transl. Med. 2, 46ra62 (2010).","journal-title":"Sci. Transl. Med."},{"key":"69054_CR14","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/j.1365-2133.2007.08167.x","volume":"157","author":"M Tohyama","year":"2007","unstructured":"Tohyama, M. et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br. J. Dermatol. 157, 934\u2013940 (2007).","journal-title":"Br. J. Dermatol."},{"key":"69054_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2133.2006.07238.x","volume":"155","author":"Y Kano","year":"2006","unstructured":"Kano, Y., Hiraharas, K., Sakuma, K. & Shiohara, T. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br. J. Dermatol. 155, 301\u2013306 (2006).","journal-title":"Br. J. Dermatol."},{"key":"69054_CR16","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1001\/archdermatol.2009.195","volume":"145","author":"Y Asano","year":"2009","unstructured":"Asano, Y., Kagawa, H., Kano, Y. & Shiohara, T. Cytomegalovirus disease during severe drug eruptions: Report of 2 cases and retrospective study of 18 patients with drug-induced hypersensitivity syndrome. Arch. Dermatol. 145, 1030\u20131036 (2009).","journal-title":"Arch. Dermatol."},{"key":"69054_CR17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jaip.2016.11.027","volume":"5","author":"J-C Roujeau","year":"2017","unstructured":"Roujeau, J.-C. & Dupin, N. Virus reactivation in drug reaction with eosinophilia and systemic symptoms (DRESS) results from a strong drug-specific immune response. J. Allergy Clin. Immunol. Pract. 5, 811\u2013812 (2017).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"69054_CR18","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","volume":"156","author":"S Kardaun","year":"2007","unstructured":"Kardaun, S. et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: Does a DRESS syndrome really exist?. Br. J. Dermatol. 156, 609\u2013611 (2007).","journal-title":"Br. J. Dermatol."},{"key":"69054_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.4450","author":"MC Bruggen","year":"2023","unstructured":"Bruggen, M. C. et al. Management of adult patients with drug reaction with eosinophilia and systemic symptoms: A Delphi-based international consensus. JAMA Dermatol. https:\/\/doi.org\/10.1001\/jamadermatol.2023.4450 (2023).","journal-title":"JAMA Dermatol."},{"key":"69054_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1001\/archderm.145.1.67","volume":"145","author":"M Eshki","year":"2009","unstructured":"Eshki, M. et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: A cause of unpredictable multiorgan failure. Arch. Dermatol. 145, 67\u201372 (2009).","journal-title":"Arch. Dermatol."},{"key":"69054_CR21","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jaad.2018.08.052","volume":"80","author":"Y Mizukawa","year":"2019","unstructured":"Mizukawa, Y., Hirahara, K., Kano, Y. & Shiohara, T. Drug-induced hypersensitivty synodrme\/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease. J. Am. Acad. Dermatol. 80, 670\u2013678 (2019).","journal-title":"J. Am. Acad. Dermatol."},{"key":"69054_CR22","first-page":"151","volume":"11","author":"L Mardivirin","year":"2007","unstructured":"Mardivirin, L., Lacroix, A., Delebass\u00e9e, S., Descamps, V. & Ranger-Rogez, S. Augmentation de la r\u00e9plication in vitro de l\u2019herp\u00e8svirus humain 6 en pr\u00e9sence de valproate de sodium. Virologie 11, 151\u2013153 (2007).","journal-title":"Virologie"},{"key":"69054_CR23","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1099\/0022-1317-76-6-1409","volume":"76","author":"G Kuntz-Simon","year":"1995","unstructured":"Kuntz-Simon, G. & Obert, G. Sodium valproate, an anticonvulsant drug, stimulates human cytomegalovirus replication. J. Gen. Virol. 76, 1409\u20131415 (1995).","journal-title":"J. Gen. Virol."},{"key":"69054_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/all.15558","volume":"78","author":"WJ Pichler","year":"2023","unstructured":"Pichler, W. J. & Bruggen, M. C. Viral infections and drug hypersensitivity. Allergy 78, 60\u201370 (2023).","journal-title":"Allergy"},{"key":"69054_CR25","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/bjd.18942","volume":"183","author":"CW Yang","year":"2020","unstructured":"Yang, C. W. et al. The interferon-gamma-induced protein 10\/CXCR3 axis is associated with human herpesvirus-6 reactivation and the development of sequelae in drug reaction with eosinophilia and systemic symptoms. Br. J. Dermatol. 183, 909\u2013919 (2020).","journal-title":"Br. J. Dermatol."},{"key":"69054_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jaad.2014.10.032","volume":"72","author":"E Funck-Brentano","year":"2015","unstructured":"Funck-Brentano, E. et al. Therapeutic management of DRESS: A retrospective study of 38 cases. J. Am. Acad. Dermatol. 72, 246\u2013252 (2015).","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69054-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69054-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69054-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T02:16:02Z","timestamp":1732241762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69054-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["69054"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-69054-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"22 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28492"}}